IL-23p40 SPECIFIC IMMUNOGLOBULIN DERIVED PROTEINS, COMPOSITIONS, METHODS AND USES

WIPO Patent Application WO2004101750

A3

Novel anti-IL-23p40 specific human Ig derived proteins, including, without limitation, antibodies, fusion proteins, and mimetibodies, isolated nucleic acids that encode the anti-IL-23p40 Ig derived proteins, vectors, host cells, transgenic animals or plants, and methods of making and using thereof, are useful for therapeutic compositions, methods and devices. Preferably, the anti-IL-23p40 specific human Ig derived proteins do not bind the p40 subunit of IL-12 and, thus, do not neutralize IL-12-related activity.

JPH11514217	Title of Invention Compounds and Methods for Diagnosis of Tuberculosis
JPH0723891	INDUSTRIAL APPLICABILITY [Title of Invention] A denatured protein analyzer, particularly Hb A 1 C immune system, and an antibody against it.
WO/1996/037211	LATENT TRANSCRIPTS AND PROMOTERS OF CYTOMEGALOVIRUS

BENSON JACQUELINE (US)
CUNNINGHAM MARK (US)

PCT/US2004/014372

December 21, 2006

May 06, 2004

Click for automatic bibliography generation  

CENTOCOR INC (US)
BENSON JACQUELINE (US)
CUNNINGHAM MARK (US)

C12P21/08; C07H21/04; C07K16/24; C12N5/06; C12N5/16; C12P21/06; C12N

US20040223969A1

2004-11-11

CUA D.J. ET AL: "Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain.", NATURE, vol. 421, 13 February 2003 (2003-02-13), pages 744 - 748, XP002971969
See also references of EP 1623011A4

View/Download PDF      PDF Help

Previous Patent: METHODS FOR AMPLIFICATION OF NUCLEIC ACID SEQUENCES USING STAGGERED LIGATION

Next Patent: A MODIFIED RUBISCO LARGE SUBUNIT ∈N-METHYLTRANSFERASE USEFUL FOR TARGETING MOLECULES TO THE ACTIVE...